About Us

Dedicated to Scientific Advancement

GemPharmatech is a leading provider of genetically modified mouse models and preclinical services to global R&D communities. We offer more than 20,000+ mouse models and can create new custom models based on your research needs.

Dr. Xiang Gao, Chairman of GemPharmatech Co. Ltd., was the founding director of the Model Animal Research Center (MARC) at Nanjing University. He has published more than 200 scientific articles focused on mouse models and disease research. In 2017, Dr. Gao founded GemPharmatech Co. Ltd., which is currently enlisted in the Shanghai Stock Exchange STAR Market. Dr. Mark Moore is the CEO of GemPharmatech LLC, the US subsidiary of GemPharmatech. Dr. Moore was a co-founder and CSO of Deltagen, the first high-throughput gene knockout and target development company, and later served as the Executive Director of the International Mouse Phenotyping Consortium (IMPC).

With their combined experience Dr. Gao, Dr. Moore, and the global GemPharmatech team are rapidly advancing preclinical mouse models and accelerating basic and translational research.


Delivering world-class preclinical solutions.

Get Started

We’re Trusted Experts

Preclinical and model customization services


Large Collection of GEMMs

20,000+ genetically engineered mouse models


Customized Models

Fast, high-quality custom mouse models

Get Started